Grandview Asset Management LLC Tandem Diabetes Care Inc Transaction History

Grandview Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$77.0 - $100.19 $4,620 - $6,011	-60 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$81.28 - $104.34 $89,001 - $114,252	-1,095 Reduced 94.81%	60 $5,000
Q1 2021 May 06, 2021	BUY	$81.28 - $104.34 $93,878 - $120,512	1,155 New	1,155 $9,000
Q1 2020 Apr 09, 2020	SELL	$47.37 - $90.04 $366,312 - $696,279	-7,733 Closed	0 $0
Q4 2019 Jan 28, 2020	SELL	$53.13 - $71.19 $61,099 - $81,868	-1,150 Reduced 12.95%	7,733 $466,000
Q3 2019 Nov 07, 2019	SELL	$57.11 - $73.3 $62,021 - $79,603	-1,086 Reduced 10.89%	8,883 $497,000
Q2 2019 Jul 18, 2019	SELL	$54.41 - $71.7 $96,033 - $126,550	-1,765 Reduced 15.04%	9,969 $643,000
Q1 2019 May 07, 2019	BUY	$32.25 - $73.56 $378,421 - $863,153	11,734 New	11,734 $745,000

348

73.1M

3.12M

343K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.13B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Grandview Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Grandview Asset Management LLC with notifications on news.